Mein Warenkorb

Integrin alpha E beta 7

Integrin alpha E beta 7 Molekülinformation

Englischer NameIntegrin alpha-E/beta-7Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-Alias
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameIntegrin alpha-E/beta-7
Target-Alias
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

Integrin alpha E beta 7 Produktliste

  • Attribut

    Protein (3)

  • Produktbibliothek

    Online (3)

  • Spezies

    Human (1)Cynomolgus (1)Mouse (1)

  • Etikett

    His Tag (3)

  • Marker

    Unconjugated (3)

Integrin alpha E beta 7 Molekülhintergrund

Integrin alpha E beta 7 consist of two major subunits: Integrin alpha E (ITGAE) also known as CD103 (cluster of differentiation 103) and Integrin beta-7 is an integrin protein that in humans is encoded by the ITGB7 gene. Integrin alpha E beta 7 (CD103) is expressed mainly by cells of the T lymphocyte lineage within mucosal tissues. This is a strikingly narrow pattern of expression compared with that of other integrins. Lymphocytes expressing alpha E beta 7 are abundant in the gut and comprise a major part of the total T cell complement of the body. The effectiveness of lung transplantation is marred by the relatively high incidence of rejection. The lung normally contains a large population of lymphocytes in contact with the airway epithelium, a proportion of which expresses the mucosal integrin, alpha(E)(CD103)beta(7). This integrin is not a homing receptor, but is thought to retain lymphocytes at the epithelial surface.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
EtrolizumabPRO-145223; rhuMAb-Beta7; R-7413; RG-7413Phase 3 ClinicalGenentech IncColitis, Ulcerative; Crohn Disease
Details
ABBV-243ABBV-243Phase 1 ClinicalAbbvie Inc
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns